ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

BCLI Company Profile and Key Details

NASDAQ : BCLI

Brainstorm Cell Therapeutics Inc.

$0.85

-0.01-1.16%

Open: 1:32 PM

68.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Brainstorm Cell Therapeutics Inc. (BCLI) stock declined over -1.16%, trading at $0.85 on NASDAQ, down from the previous close of $0.86. The stock opened at $0.84, fluctuating between $0.84 and $0.89 in the recent session.

Stock Snapshot

0.86

Prev. Close

0.84

Open

5.54M

Market Cap

6.52M

Number of Shares

0.8442

Day Low

0.89

Day High

-0.37

P/E Ratio

77.68%

Free Float in %

-2.31

EPS (TTM)

-0.1

Book Value

-0.41

Cash Flow per Share

17.59K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 21, 2025	0.91	0.91	0.85	0.86	79.19K
Apr 17, 2025	0.81	0.91	0.78	0.88	48.31K
Apr 16, 2025	0.74	0.81	0.72	0.80	106.95K
Apr 15, 2025	0.80	0.82	0.72	0.78	68.96K
Apr 14, 2025	0.75	0.79	0.75	0.78	58.45K
Apr 11, 2025	0.90	0.90	0.75	0.76	357.97K
Apr 10, 2025	1.04	1.11	0.81	0.91	5.97M
Apr 09, 2025	1.08	1.15	1.00	1.11	73.25K
Apr 08, 2025	1.22	1.22	1.07	1.09	25.48K
Apr 07, 2025	1.19	1.27	1.11	1.12	35.48K
Apr 04, 2025	1.21	1.21	1.15	1.15	11.66K
Apr 03, 2025	1.24	1.25	1.15	1.23	28.2K
Apr 02, 2025	1.18	1.28	1.15	1.21	28.22K
Apr 01, 2025	1.17	1.25	1.17	1.19	28.29K
Mar 31, 2025	1.19	1.28	1.12	1.26	70.71K
Mar 28, 2025	1.35	1.35	1.18	1.19	85.02K
Mar 27, 2025	1.34	1.42	1.34	1.35	16.34K
Mar 26, 2025	1.59	1.59	1.39	1.40	43.23K
Mar 25, 2025	1.43	1.56	1.37	1.44	28.7K
Mar 24, 2025	1.45	1.45	1.35	1.37	31.98K

Contact Details

New York, NY 10019

United States

Website: https://www.brainstorm-cell.comContact: 201 488 0460

About Company

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current Brainstorm Cell Therapeutics Inc. (BCLI) stock price?

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) stock price is $0.85 in the last trading session. During the trading session, BCLI stock reached the peak price of $0.89 while $0.84 was the lowest point it dropped to. The percentage change in BCLI stock occurred in the recent session was -1.16% while the dollar amount for the price change in BCLI stock was -$0.01.

BCLI's industry and sector of operation?

The NASDAQ listed BCLI is part of Biotechnology industry that operates in the broader Healthcare sector. Brainstorm Cell Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BCLI?

Dr. Ralph Z. Kern
Pres & Chief Medical Officer
Mr. Chaim Lebovits
Chief Executive Officer
Ms. Mary Kay Turner
Senior Vice President of Patient Advocacy & Gov. Affairs
Ms. Alla Patlis CPA, M.B.A.
Controller & Interim Chief Financial Officer
Mr. Uri Yablonka
Executive Vice President, Chief Bus. Officer, Sec. & Director
Dr. Yael Gothelf
Vice President of Scientific & Regulatory Affairs
Dr. Irit Arbel DSc, Ph.D.
Co-Founder & Independent Vice Chair of the Board
Dr. David Setboun M.B.A., Pharm.D.
Executive Vice President & Chief Operating Officer
Ms. Antal Pearl-Lendner
Vice President & Chief Legal Counsel
Dr. Stacy R. Lindborg Ph.D.
Co-Chief Executive Officer
Dr. Daniel Offen Ph.D.
Chief Scientific Advisor
Dr. Ralph Z. Kern M.D., MHSc
Pres & Chief Medical Officer
Mr. William K. White
Senior Vice President & Head of Market Access and Pricing

How BCLI did perform over past 52-week?

BCLI's closing price is 19.44% higher than its 52-week low of $0.72 where as its distance from 52-week high of $10.05 is -91.44%.

How many employees does BCLI have?

Number of BCLI employees currently stands at 27.

Link for BCLI official website?

Official Website of BCLI is: https://www.brainstorm-cell.com

How do I contact BCLI?

BCLI could be contacted at phone 201 488 0460 and can also be accessed through its website. BCLI operates from 1325 Avenue of Americas, New York, NY 10019, United States.

How many shares of BCLI are traded daily?

BCLI stock volume for the day was 17.59K shares. The average number of BCLI shares traded daily for last 3 months was 143.57K.

What is the market cap of BCLI currently?

The market value of BCLI currently stands at $5.54M with its latest stock price at $0.85 and 6.52M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Stock Snapshot

0.86

Prev. Close

0.84

Open

5.54M

Market Cap

6.52M

Number of Shares

0.8442

Day Low

0.89

Day High

-0.37

P/E Ratio

77.68%

Free Float in %

-2.31

EPS (TTM)

-0.1

Book Value

-0.41

Cash Flow per Share

17.59K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 21, 2025	0.91	0.91	0.85	0.86	79.19K
Apr 17, 2025	0.81	0.91	0.78	0.88	48.31K
Apr 16, 2025	0.74	0.81	0.72	0.80	106.95K
Apr 15, 2025	0.80	0.82	0.72	0.78	68.96K
Apr 14, 2025	0.75	0.79	0.75	0.78	58.45K
Apr 11, 2025	0.90	0.90	0.75	0.76	357.97K
Apr 10, 2025	1.04	1.11	0.81	0.91	5.97M
Apr 09, 2025	1.08	1.15	1.00	1.11	73.25K
Apr 08, 2025	1.22	1.22	1.07	1.09	25.48K
Apr 07, 2025	1.19	1.27	1.11	1.12	35.48K
Apr 04, 2025	1.21	1.21	1.15	1.15	11.66K
Apr 03, 2025	1.24	1.25	1.15	1.23	28.2K
Apr 02, 2025	1.18	1.28	1.15	1.21	28.22K
Apr 01, 2025	1.17	1.25	1.17	1.19	28.29K
Mar 31, 2025	1.19	1.28	1.12	1.26	70.71K
Mar 28, 2025	1.35	1.35	1.18	1.19	85.02K
Mar 27, 2025	1.34	1.42	1.34	1.35	16.34K
Mar 26, 2025	1.59	1.59	1.39	1.40	43.23K
Mar 25, 2025	1.43	1.56	1.37	1.44	28.7K
Mar 24, 2025	1.45	1.45	1.35	1.37	31.98K

Contact Details

New York, NY 10019

United States

Website: https://www.brainstorm-cell.comContact: 201 488 0460

About Company

Frequently Asked Questions

What is the current Brainstorm Cell Therapeutics Inc. (BCLI) stock price?

BCLI's industry and sector of operation?

Who are the executives of BCLI?

How BCLI did perform over past 52-week?

BCLI's closing price is 19.44% higher than its 52-week low of $0.72 where as its distance from 52-week high of $10.05 is -91.44%.

How many employees does BCLI have?

Number of BCLI employees currently stands at 27.

Link for BCLI official website?

Official Website of BCLI is: https://www.brainstorm-cell.com

How do I contact BCLI?

BCLI could be contacted at phone 201 488 0460 and can also be accessed through its website. BCLI operates from 1325 Avenue of Americas, New York, NY 10019, United States.

How many shares of BCLI are traded daily?

BCLI stock volume for the day was 17.59K shares. The average number of BCLI shares traded daily for last 3 months was 143.57K.

What is the market cap of BCLI currently?

The market value of BCLI currently stands at $5.54M with its latest stock price at $0.85 and 6.52M of its shares outstanding.

Employees	27
Beta	0.59
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	27
Beta	0.59
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BCLI Company Profile and Key Details

Brainstorm Cell Therapeutics Inc.

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions